{
    "paper_id": "PMC7191299",
    "metadata": {
        "title": "COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach",
        "authors": [
            {
                "first": "Giovanna",
                "middle": [],
                "last": "Borriello",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Antonio",
                "middle": [],
                "last": "Ianniello",
                "suffix": "",
                "email": "antonio.ianniello@uniroma1.it",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "The authors report no conflict of interest.",
            "cite_spans": [],
            "section": "Declaration of Competing Interest",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "A Novel Coronavirus from Patients with Pneumonia in China, 2019",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "382",
            "issn": "8",
            "pages": "727-733",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "10223",
            "pages": "497-506",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Poyiadji",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Shahin",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Noujaim",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Radiology",
            "volume": "201187",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Clerico",
                    "suffix": ""
                },
                {
                    "first": "SF",
                    "middle": [],
                    "last": "De Mercanti",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Signori",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Neurotherapeutics",
            "volume": "17",
            "issn": "1",
            "pages": "200-207",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study",
            "authors": [
                {
                    "first": "RJ",
                    "middle": [],
                    "last": "Fox",
                    "suffix": ""
                },
                {
                    "first": "BA",
                    "middle": [],
                    "last": "Cree",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De S\u00e8ze",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Neurology",
            "volume": "82",
            "issn": "17",
            "pages": "1491-1498",
            "other_ids": {
                "DOI": []
            }
        }
    }
}